Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, following the announcement on the19 December 2025 on the NIHR Brain Tumour Research Consortium, when the additional announcements will be made on further funding into brain tumour treatment trials beyond the £13.7 million initial investment.

Research is crucial in tackling cancer, which is why the Department invests over £1.7 billion per year in research through the National Institute for Health and Care Research (NIHR). The NIHR Brain Tumour Research Consortium was announced as part of the Government’s commitment to developing new lifesaving and life-improving research, supporting those diagnosed and living with brain tumours.

In December 2025, the NIHR announced an initial £13.7 million investment in the Brain Tumour Research Consortium. In January 2026, the NIHR announced further investment of a minimum of £11.7 million in the Consortium through funding of work packages. This brings the total investment to over £25 million. Payments will be issued over the period of the award contracts which range from five to ten years, as per the schedule of payments agreed between NIHR and the consortium.

We are expecting to be able to make further updates on the progress of the NIHR Brain Cancer Consortium in due course. The NIHR is working to ensure that new investments can get up and running as soon as possible.

In addition, the NIHR continues to strongly encourages brain cancer research applications through its regular funding opportunities.